Dr. Eric P. Yang is the Chief Executive Officer of Inti Labs, where he currently spearheads the corporate strategies and business development of the company. Prior to joining Inti, he served as the Chief Executive Officer at Quark Biosciences. Eric has over 15 years of experience in both the biotechnology and consumer industries.

Eric majored in biochemistry and molecular biology at the University of California, Los Angeles (UCLA). After receiving his bachelor’s and doctoral degrees at UCLA on small non-coding RNAs, he continued his research in long non-coding RNAs as a Howard Hughes Medical Institute Scholar at Harvard Medical School. He has co-authored a number of key papers and a major review on the roles of non-coding RNAs.

Additionally, Eric also serves as the Secretary General of the Precision Medicine Industry Association of Taiwan, which aims to accelerate the development of personalized medicine industry in Taiwan. As an entrepreneur at heart, he co-founded a number of successful businesses during his time in the United States.